LBB Specialties Expands Distribution Partnership with Clariant to Support Puerto Rico's Life Sciences Market
Under this expanded agreement, LBB Specialties will now support the Puerto Rico market with Clariant's full excipient portfolio, locally stocked inventory, and dedicated technical and commercial support on the island.
This collaboration strengthens LBBS's ability to deliver high-purity, GMP-compliant excipients tailored for pharmaceutical and biopharmaceutical applications, including products designed for low endotoxin and tight microbial control.
"Puerto Rico continues to be a preferred destination for companies establishing FDA-approved pharmaceutical manufacturing operations," said Seth Burns, Senior Vice President, Life Sciences at LBB Specialties. "By expanding our partnership with Clariant, we're reinforcing our commitment to supporting the region's Life Sciences ecosystem with best-in-class excipients and responsive local service. This expansion builds on our shared vision of advancing formulation innovation while ensuring supply chain reliability and technical excellence."
"This expanded partnership with LBB Specialties represents a strategic advancement in our commitment to strengthening our global footprint," said Vaios Barlas, Head of Health Care at Clariant. "Local availability of our complete excipient portfolio directly addresses the needs of this important market. Clariant values LBBS's established presence and technical capabilities in Puerto Rico, which complement our focus on delivering pharmaceutical-grade ingredients that meet the highest quality and regulatory standards."
For more information about Clariant's excipient solutions in Puerto Rico, please contact LBB Specialties today.
About LBB Specialties
LBB Specialties is a leader in North American specialty chemicals and ingredients distribution. It is a diversified supplier serving end markets including care, food & nutrition, industrial specialties, and life sciences. www.LBBSpecialties.com
About Clariant
Clariant is a focused specialty chemical company led by the overarching purpose of "Greater chemistry – between people and planet." By connecting customer focus, innovation, and people, the company creates solutions to foster sustainability in different industries. On 31 December 2024, Clariant totaled a staff number of 10 465 and recorded sales of CHF 4.152 billion in the fiscal year for its continuing businesses. Since January 2023, the Group conducts its business through the three Business Units Care Chemicals, Catalysts, and Adsorbents & Additives. Clariant is based in Switzerland.
Clariant Health Care is a leading high-quality solution partner for the global pharmaceutical industry, with a strong portfolio of top-performing excipients and active pharmaceutical ingredients (APIs), backed by operational excellence and years of experience in regulatory affairs. https://www.clariant.com/HealthCare
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
13 hours ago
- Cision Canada
Arrive AI selects Synoptek as a Strategic IT Partner
COSTA MESA, Calif. and INDIANAPOLIS, July 14, 2025 /CNW/ -- Arrive AI (NASDAQ: ARAI) — a pioneering autonomous delivery network anchored by Arrive Points™ — has selected Synoptek as a strategic IT partner to enable its rapid growth and global ambitions. Synoptek will provide Arrive AI with all the IT solutions it needs to support its business. With a recent $40 million injection of funding from Streeterville Capital, Arrive AI is entering a critical growth phase. The company is preparing to launch its patented, autonomous delivery platform later this summer and expects to double its staff size. "Synoptek's strategic approach, deep expertise, robust tech stack and strong partnerships with Microsoft and ServiceNow made it a clear choice," said Mark Hamm, COO of Arrive AI. "We were searching for a partner who could move at our pace and help us build a resilient IT foundation. After conducting an exhaustive search, we knew Synoptek would be the partner we were looking for to provide all of the IT capabilities we need to take our business to the next level." Under the three-year agreement, Synoptek will contribute to the solution definition, implementation and IT management, including, cybersecurity, enterprise-grade IT and 24/7 AI-enabled managed services operations. This engagement deepens Synoptek's presence in the high-growth logistics and manufacturing sector and aligns with its mission to deliver smart, secure and connected IT environments. "We're proud to serve as an extension of the Arrive AI team," said Salil Godika, CEO at Synoptek. "Together, we are building a resilient and secure IT backbone that supports innovation and scale. We deliver focused solutions that incorporate exceptional customer experiences, digital application engineering, and agile infrastructure. We are committed to providing Arrive AI with the technology foundation it needs to grow with confidence." Synoptek will provide advisory services and information sharing around security, AI and application innovation as Arrive AI continues to push boundaries in the AI transportation and logistics space. About Arrive AI Arrive AI's patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox, whether by drone, ground robot or human courier. The platform provides real-time tracking, smart logistics alerts and advanced chain of custody controls to support shippers, delivery services and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting and security systems to streamline the entire last-mile delivery experience. Learn more at About Synoptek Synoptek is a global, full-service business and digital technology solutions provider and advisory firm that helps companies envision, transform, and evolve their customer experiences, application ecosystems, and infrastructures. As a systems integrator and managed technology provider, Synoptek partners with organizations worldwide, helping them navigate the ever-changing technology landscape and build solid tech foundations for their businesses. With its comprehensive offerings, global workforce, and strategic technology partnerships, Synoptek helps companies optimize their IT environments and enable innovation through technology. With growth, ownership, inclusiveness, and philanthropy embedded in its DNA, Synoptek is committed to delivering improved business results and unmatched service to all its stakeholders. Cautionary Note Regarding Forward Looking Statements This news release and statements of Arrive AI's management in connection with this news release or related events contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects", "anticipates", "intends", "plans", "believes", "potential", "will", "should", "could", "would", "optimistic" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Arrive AI's Registration Statement for more complete information, including the risk factors that may affect future results, which are available for review at Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.
Cision Canada
14 hours ago
- Cision Canada
Vention Launches Next-Generation Modular Palletizer to Power its End-of-Line Automation Solutions
Vention's updated Rapid Series Palletizer features the industry's highest vertical stacking reach, built-in mobility for fast relocation, and software enhancements for effortless pallet recipe creation, including support for unlimited SKUs. This turnkey solution, offered with robots from FANUC and Universal Robots, supports payloads up to 30 kg (66 lbs) with a collaborative robot and up to 140 kg (308 lbs) with an available industrial robot. In addition to boxes, Vention's palletizer supports palletizing of bags, trays, and pails with compatible grippers and other features. As part of Vention's fully integrated automation platform, the Rapid Series Palletizer uses modular hardware that accelerates deployment and scalability with Vention's other end-of-line solutions, including box erecting and case packing. The Rapid Series Palletizer comes out of the box with live video support directly from the pendant within 10 minutes, 24/7 remote live streaming, and an analytics platform for real-time diagnostics and fleet performance tracking. MONTREAL, July 14, 2025 /CNW/ - Vention, creator of the world's only full-stack automation platform and hardware ecosystem, today announced the launch of its next-generation Rapid Series Palletizer: the industry's most versatile palletizing solution engineered for unmatched deployment speed. Available for purchase today, the updated Rapid Series Palletizer will make its North American debut, with a live demo, from September 29 through October 1 at Pack Expo Las Vegas in Booth No. SL-16020. Designed for manufacturers facing labor challenges, a high mix of SKUs, and rising automation demands, the Rapid Series Palletizer brings together plug-and-play hardware, intuitive software, analytics capabilities and remote support into a single, modular palletizing system that can be installed and configured in days. "Vention's Rapid Series Palletizer is already a popular choice in North America, trusted by small manufacturers looking for a reliable one-stop-shop to Fortune 500 food and consumer products companies seeking global roll-out of a standardized solution," said Francois Giguère, Vention's Chief Technology Officer. "Our goal with this release was simple: make end-of-line palletizing even smarter, more mobile, and ready for anything. Our modular ecosystem also enables manufacturers to easily add on other end-of-line options and ensure they are completely compatible out of the box." Key Features of the Rapid Series Palletizer Built on Vention's proven FastFactory™ plug-and-play hardware ecosystem, trusted in tens of thousands of projects, this next-generation palletizer sets a new benchmark for reliability and performance. Key features include: Customizable and Plug-and-Play: Easily integrates with modular grippers and conveyors to adapt to any product type or size. Best-in-Class Vertical Reach: Achieve stack heights up to 136 inches with an optional riser—the highest in its category. Easy Operation: Intuitive software enables rapid pallet recipe creation and unlimited SKU configurations, minimizing training time. Enhanced Mobility: A redesigned base supports both pallet jacks and forklifts for quick, anchor-free relocation across the factory floor. Real-Time Expert Support: Access live video assistance from automation specialists directly through the machine pendant. Data-Driven Performance: Monitor operations remotely and unlock actionable insights with built-in analytics and remote live video stream to maximize throughput and uptime. A Complete End-of-Line Ecosystem When combined with Vention's modular conveyors, box erectors, and case packers, the Rapid Series Palletizer is part of an interconnected end-of-line ecosystem, all managed through a unified software interface. This modularity empowers facilities to scale their automation with minimal downtime and no custom integration work across multiple production sites. To learn more, visit Christine Boivin +1.514.293.3423 [email protected] About Vention Vention is leading the future of industrial automation by enabling businesses of all sizes to automate faster than ever — boosting productivity, cutting costs, and driving scalable growth. With our free, drag-and-drop MachineBuilder™ software and modular, plug-and-play FastFactory™ hardware ecosystem, Vention helps businesses automate with unmatched speed, simplicity, and success. Our unified software and hardware automation platform enables businesses to design, simulate, deploy, and operate turnkey or custom automation solutions in just days. Trusted by 4,000+ customers across five continents, Vention is redefining the automation experience with exceptional technology and customer service. Visit to learn more. SOURCE Vention Inc.
Cision Canada
15 hours ago
- Cision Canada
Aurora Completes First-Ever EU-GMP Certification for the Company's Dedicated Distribution Centre
Adding a fourth certified facility within its global network increases operational capacity to better serve international medical markets NASDAQ| TSX: EDMONTON, AB, July 14, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce that its dedicated distribution centre located in Brampton, Ontario, has received European Union Good Manufacturing Practice ("EU-GMP") certification, increasing the company's international export capabilities. The distribution centre joins Aurora's group of manufacturing facilities in Canada and Europe certified against EU standards, demonstrating the company's unwavering commitment to regulatory excellence, end-to-end operational quality assurance, and global supply chain efficiency. "Securing EU-GMP certification at manufacturing and distribution facilities within our network is an important validation of our differentiated approach to operating as a global medical cannabis company," said Jill Lau, Vice President of Canadian Operations at Aurora. "By adding certification for our distribution centre, we are now uniquely positioned to ensure patients worldwide have consistent access to superior quality medical cannabis from the largest Canadian exporter." EU-GMP certification is granted to companies whose production facilities meet the requirements under the EudraLex "Rules Governing Medicinal Products in the European Union," and that can demonstrate a high degree of quality and consistency in their manufacturing procedures, a requirement for the export of medical cannabis products into Europe. EU-GMP certification of the company's distribution centre allows it to serve as a centralized site for more optimized and efficient receipt, storage and distribution of materials and finished products internationally. With operations across Canada and in Europe, Aurora remains at the forefront of the global medical cannabis industry. By continuously investing in operational capabilities, regulatory excellence, and a science-led approach, Aurora is best positioned to deliver high-quality medical cannabis that meets and exceeds the highest international standards. About Aurora Cannabis Inc. Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at and follow us on X and LinkedIn. Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB". Forward Looking Information This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law (" forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the EU-GMP certification for the Company's dedicated distribution centre and benefits for the Company, including increases to operational capacity for international medical markets; statements regarding the Company's ability to meet patient demand globally; and the Company's commitment to regulatory excellence, end-to-end operational quality assurance and global supply chain efficiency. These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the magnitude and duration of potential new or increased tariffs imposed on goods imported from Canada into the United States; the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information from dated June 17, 2025 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at and filed with and available on the SEC's website at The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law. SOURCE Aurora Cannabis Inc.
